 | • レポートコード：MRC23Q36409 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、85ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の治療薬モニタリング（TDM）サービス市場について調査・分析し、世界の治療薬モニタリング（TDM）サービス市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（血液検査、尿検査、唾液検査）、用途別セグメント分析（病院検査室、独立臨床検査室、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Roche、Danaher、Abbott、Thermo Fisher Scientific、Siemens Healthineers、Bio-Rad Laboratories、bioMerieux、Bühlmann Laboratories、Randox Laboratories、Sekisui Medicalなどが含まれています。 世界の治療薬モニタリング（TDM）サービス市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、治療薬モニタリング（TDM）サービス市場規模を推定する際に考慮しました。本レポートは、治療薬モニタリング（TDM）サービスの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、治療薬モニタリング（TDM）サービスに関するビジネス上の意思決定に役立てることを目的としています。 ・治療薬モニタリング（TDM）サービス市場の概要 - 治療薬モニタリング（TDM）サービスのタイプ別セグメント - 世界の治療薬モニタリング（TDM）サービス市場規模：タイプ別分析（血液検査、尿検査、唾液検査） - 治療薬モニタリング（TDM）サービスの用途別セグメント - 世界の治療薬モニタリング（TDM）サービス市場規模：用途別分析（病院検査室、独立臨床検査室、その他） - 世界の治療薬モニタリング（TDM）サービス市場規模予測（2018年-2029年） ・治療薬モニタリング（TDM）サービス市場の成長トレンド - 治療薬モニタリング（TDM）サービスの地域別市場規模（2018年-2029年） - 治療薬モニタリング（TDM）サービス市場ダイナミクス - 治療薬モニタリング（TDM）サービスの業界動向 - 治療薬モニタリング（TDM）サービス市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：血液検査、尿検査、唾液検査 - 世界の治療薬モニタリング（TDM）サービスのタイプ別市場規模（2018年-2023年） - 世界の治療薬モニタリング（TDM）サービスのタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院検査室、独立臨床検査室、その他 - 世界の治療薬モニタリング（TDM）サービスの用途別市場規模（2018年-2023年） - 世界の治療薬モニタリング（TDM）サービスの用途別市場規模（2024年-2029年） ・治療薬モニタリング（TDM）サービスの地域別市場規模 - 北米の治療薬モニタリング（TDM）サービス市場規模（2018年-2029年） - アメリカの治療薬モニタリング（TDM）サービス市場規模（2018年-2029年） - ヨーロッパの治療薬モニタリング（TDM）サービス市場規模（2018年-2029年） - アジア太平洋の治療薬モニタリング（TDM）サービス市場規模（2018年-2029年） - 中国の治療薬モニタリング（TDM）サービス市場規模（2018年-2029年） - 日本の治療薬モニタリング（TDM）サービス市場規模（2018年-2029年） - 韓国の治療薬モニタリング（TDM）サービス市場規模（2018年-2029年） - インドの治療薬モニタリング（TDM）サービス市場規模（2018年-2029年） - オーストラリアの治療薬モニタリング（TDM）サービス市場規模（2018年-2029年） - 中南米の治療薬モニタリング（TDM）サービス市場規模（2018年-2029年） - 中東・アフリカの治療薬モニタリング（TDM）サービス市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Roche、Danaher、Abbott、Thermo Fisher Scientific、Siemens Healthineers、Bio-Rad Laboratories、bioMerieux、Bühlmann Laboratories、Randox Laboratories、Sekisui Medical ・アナリストの観点/結論 ・調査方法とデータソース |
Therapeutic drug monitoring (TDM), a clinical laboratory technology that measures drug concentrations to regulate drug dosage, has become an important treatment aid in both inpatient and ambulatory care. TDM laboratory methods, including immunoassay (EIA, FIA, and RIA) and chromatographic techniques, used to assay blood, urine, and saliva samples of patients taking therapeutic drugs; TDM is also useful in identifying abused drugs.
Therapeutic drug monitoring (TDM) is the clinical practice of measuring specific drugs at designated intervals to maintain a constant concentration in a patient’s bloodstream, thereby optimizing individual dosage regimens. It is unnecessary to employ TDM for the majority of medications, and it is used mainly for monitoring drugs with narrow therapeutic ranges, drugs with marked pharmacokinetic variability, medications for which target concentrations are difficult to monitor, and drugs known to cause therapeutic and adverse effects.
Highlights
The global Therapeutic Drug Monitoring (TDM) Service market was valued at US$ 1875.1 million in 2022 and is anticipated to reach US$ 2292.9 million by 2029, witnessing a CAGR of 3.4% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global therapeutic drug monitoring key players include Roche, Danaher and Abbott.The top 5 accounts for 60% of the revenue. By region, North America had the highest share of income, reaching 45 percent.In terms of product, blood test is the largest segment, with a share over 70%. And in terms of application, the largest application is hospital labs, followed by independent clinical laboratories.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Therapeutic Drug Monitoring (TDM) Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Drug Monitoring (TDM) Service.
The Therapeutic Drug Monitoring (TDM) Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Therapeutic Drug Monitoring (TDM) Service market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Therapeutic Drug Monitoring (TDM) Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Roche
Danaher
Abbott
Thermo Fisher Scientific
Siemens Healthineers
Bio-Rad Laboratories
bioMerieux
Bühlmann Laboratories
Randox Laboratories
Sekisui Medical
Segment by Type
Blood Test
Urine Test
Saliva Test
Segment by Application
Hospital Labs
Independent Clinical Laboratories
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Therapeutic Drug Monitoring (TDM) Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Therapeutic Drug Monitoring (TDM) Service Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Blood Test
1.2.3 Urine Test
1.2.4 Saliva Test
1.3 Market by Application
1.3.1 Global Therapeutic Drug Monitoring (TDM) Service Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital Labs
1.3.3 Independent Clinical Laboratories
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Therapeutic Drug Monitoring (TDM) Service Market Perspective (2018-2029)
2.2 Therapeutic Drug Monitoring (TDM) Service Growth Trends by Region
2.2.1 Global Therapeutic Drug Monitoring (TDM) Service Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Therapeutic Drug Monitoring (TDM) Service Historic Market Size by Region (2018-2023)
2.2.3 Therapeutic Drug Monitoring (TDM) Service Forecasted Market Size by Region (2024-2029)
2.3 Therapeutic Drug Monitoring (TDM) Service Market Dynamics
2.3.1 Therapeutic Drug Monitoring (TDM) Service Industry Trends
2.3.2 Therapeutic Drug Monitoring (TDM) Service Market Drivers
2.3.3 Therapeutic Drug Monitoring (TDM) Service Market Challenges
2.3.4 Therapeutic Drug Monitoring (TDM) Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Therapeutic Drug Monitoring (TDM) Service Players by Revenue
3.1.1 Global Top Therapeutic Drug Monitoring (TDM) Service Players by Revenue (2018-2023)
3.1.2 Global Therapeutic Drug Monitoring (TDM) Service Revenue Market Share by Players (2018-2023)
3.2 Global Therapeutic Drug Monitoring (TDM) Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Therapeutic Drug Monitoring (TDM) Service Revenue
3.4 Global Therapeutic Drug Monitoring (TDM) Service Market Concentration Ratio
3.4.1 Global Therapeutic Drug Monitoring (TDM) Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Therapeutic Drug Monitoring (TDM) Service Revenue in 2022
3.5 Therapeutic Drug Monitoring (TDM) Service Key Players Head office and Area Served
3.6 Key Players Therapeutic Drug Monitoring (TDM) Service Product Solution and Service
3.7 Date of Enter into Therapeutic Drug Monitoring (TDM) Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Therapeutic Drug Monitoring (TDM) Service Breakdown Data by Type
4.1 Global Therapeutic Drug Monitoring (TDM) Service Historic Market Size by Type (2018-2023)
4.2 Global Therapeutic Drug Monitoring (TDM) Service Forecasted Market Size by Type (2024-2029)
5 Therapeutic Drug Monitoring (TDM) Service Breakdown Data by Application
5.1 Global Therapeutic Drug Monitoring (TDM) Service Historic Market Size by Application (2018-2023)
5.2 Global Therapeutic Drug Monitoring (TDM) Service Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Therapeutic Drug Monitoring (TDM) Service Market Size (2018-2029)
6.2 North America Therapeutic Drug Monitoring (TDM) Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Therapeutic Drug Monitoring (TDM) Service Market Size by Country (2018-2023)
6.4 North America Therapeutic Drug Monitoring (TDM) Service Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Therapeutic Drug Monitoring (TDM) Service Market Size (2018-2029)
7.2 Europe Therapeutic Drug Monitoring (TDM) Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Therapeutic Drug Monitoring (TDM) Service Market Size by Country (2018-2023)
7.4 Europe Therapeutic Drug Monitoring (TDM) Service Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Therapeutic Drug Monitoring (TDM) Service Market Size (2018-2029)
8.2 Asia-Pacific Therapeutic Drug Monitoring (TDM) Service Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Therapeutic Drug Monitoring (TDM) Service Market Size by Region (2018-2023)
8.4 Asia-Pacific Therapeutic Drug Monitoring (TDM) Service Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Therapeutic Drug Monitoring (TDM) Service Market Size (2018-2029)
9.2 Latin America Therapeutic Drug Monitoring (TDM) Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Therapeutic Drug Monitoring (TDM) Service Market Size by Country (2018-2023)
9.4 Latin America Therapeutic Drug Monitoring (TDM) Service Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Therapeutic Drug Monitoring (TDM) Service Market Size (2018-2029)
10.2 Middle East & Africa Therapeutic Drug Monitoring (TDM) Service Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Therapeutic Drug Monitoring (TDM) Service Market Size by Country (2018-2023)
10.4 Middle East & Africa Therapeutic Drug Monitoring (TDM) Service Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Therapeutic Drug Monitoring (TDM) Service Introduction
11.1.4 Roche Revenue in Therapeutic Drug Monitoring (TDM) Service Business (2018-2023)
11.1.5 Roche Recent Development
11.2 Danaher
11.2.1 Danaher Company Detail
11.2.2 Danaher Business Overview
11.2.3 Danaher Therapeutic Drug Monitoring (TDM) Service Introduction
11.2.4 Danaher Revenue in Therapeutic Drug Monitoring (TDM) Service Business (2018-2023)
11.2.5 Danaher Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott Therapeutic Drug Monitoring (TDM) Service Introduction
11.3.4 Abbott Revenue in Therapeutic Drug Monitoring (TDM) Service Business (2018-2023)
11.3.5 Abbott Recent Development
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Detail
11.4.2 Thermo Fisher Scientific Business Overview
11.4.3 Thermo Fisher Scientific Therapeutic Drug Monitoring (TDM) Service Introduction
11.4.4 Thermo Fisher Scientific Revenue in Therapeutic Drug Monitoring (TDM) Service Business (2018-2023)
11.4.5 Thermo Fisher Scientific Recent Development
11.5 Siemens Healthineers
11.5.1 Siemens Healthineers Company Detail
11.5.2 Siemens Healthineers Business Overview
11.5.3 Siemens Healthineers Therapeutic Drug Monitoring (TDM) Service Introduction
11.5.4 Siemens Healthineers Revenue in Therapeutic Drug Monitoring (TDM) Service Business (2018-2023)
11.5.5 Siemens Healthineers Recent Development
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Detail
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories Therapeutic Drug Monitoring (TDM) Service Introduction
11.6.4 Bio-Rad Laboratories Revenue in Therapeutic Drug Monitoring (TDM) Service Business (2018-2023)
11.6.5 Bio-Rad Laboratories Recent Development
11.7 bioMerieux
11.7.1 bioMerieux Company Detail
11.7.2 bioMerieux Business Overview
11.7.3 bioMerieux Therapeutic Drug Monitoring (TDM) Service Introduction
11.7.4 bioMerieux Revenue in Therapeutic Drug Monitoring (TDM) Service Business (2018-2023)
11.7.5 bioMerieux Recent Development
11.8 Bühlmann Laboratories
11.8.1 Bühlmann Laboratories Company Detail
11.8.2 Bühlmann Laboratories Business Overview
11.8.3 Bühlmann Laboratories Therapeutic Drug Monitoring (TDM) Service Introduction
11.8.4 Bühlmann Laboratories Revenue in Therapeutic Drug Monitoring (TDM) Service Business (2018-2023)
11.8.5 Bühlmann Laboratories Recent Development
11.9 Randox Laboratories
11.9.1 Randox Laboratories Company Detail
11.9.2 Randox Laboratories Business Overview
11.9.3 Randox Laboratories Therapeutic Drug Monitoring (TDM) Service Introduction
11.9.4 Randox Laboratories Revenue in Therapeutic Drug Monitoring (TDM) Service Business (2018-2023)
11.9.5 Randox Laboratories Recent Development
11.10 Sekisui Medical
11.10.1 Sekisui Medical Company Detail
11.10.2 Sekisui Medical Business Overview
11.10.3 Sekisui Medical Therapeutic Drug Monitoring (TDM) Service Introduction
11.10.4 Sekisui Medical Revenue in Therapeutic Drug Monitoring (TDM) Service Business (2018-2023)
11.10.5 Sekisui Medical Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details